2112 related articles for article (PubMed ID: 25604547)
21. Amyloid-β oligomers in cellular models of Alzheimer's disease.
Fontana IC; Zimmer AR; Rocha AS; Gosmann G; Souza DO; Lourenco MV; Ferreira ST; Zimmer ER
J Neurochem; 2020 Nov; 155(4):348-369. PubMed ID: 32320074
[TBL] [Abstract][Full Text] [Related]
22. Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs).
Viola KL; Velasco PT; Klein WL
J Nutr Health Aging; 2008 Jan; 12(1):51S-7S. PubMed ID: 18165846
[TBL] [Abstract][Full Text] [Related]
23. Toxic amyloid-β oligomers induced self-replication in astrocytes triggering neuronal injury.
Wang W; Hou TT; Jia LF; Wu QQ; Quan MN; Jia JP
EBioMedicine; 2019 Apr; 42():174-187. PubMed ID: 30926423
[TBL] [Abstract][Full Text] [Related]
24. A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-β oligomers.
Sebollela A; Cline EN; Popova I; Luo K; Sun X; Ahn J; Barcelos MA; Bezerra VN; Lyra E Silva NM; Patel J; Pinheiro NR; Qin LA; Kamel JM; Weng A; DiNunno N; Bebenek AM; Velasco PT; Viola KL; Lacor PN; Ferreira ST; Klein WL
J Neurochem; 2017 Sep; 142(6):934-947. PubMed ID: 28670737
[TBL] [Abstract][Full Text] [Related]
25. The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer's Disease.
Viola KL; Bicca MA; Bebenek AM; Kranz DL; Nandwana V; Waters EA; Haney CR; Lee M; Gupta A; Brahmbhatt Z; Huang W; Chang TT; Peck A; Valdez C; Dravid VP; Klein WL
Front Neurosci; 2021; 15():768646. PubMed ID: 35046767
[TBL] [Abstract][Full Text] [Related]
26. Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers.
Wilcox KC; Marunde MR; Das A; Velasco PT; Kuhns BD; Marty MT; Jiang H; Luan CH; Sligar SG; Klein WL
PLoS One; 2015; 10(4):e0125263. PubMed ID: 25928376
[TBL] [Abstract][Full Text] [Related]
27. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
[TBL] [Abstract][Full Text] [Related]
28. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
[TBL] [Abstract][Full Text] [Related]
29. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.
Taniguchi K; Yamamoto F; Arai T; Yang J; Sakai Y; Itoh M; Mamada N; Sekiguchi M; Yamada D; Saitoh A; Kametani F; Tamaoka A; Araki YM; Wada K; Mizusawa H; Araki W
J Alzheimers Dis; 2019; 70(3):937-952. PubMed ID: 31227651
[TBL] [Abstract][Full Text] [Related]
30. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
[TBL] [Abstract][Full Text] [Related]
31. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
[TBL] [Abstract][Full Text] [Related]
32. The Toxicity and Polymorphism of β-Amyloid Oligomers.
Huang YR; Liu RT
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599696
[TBL] [Abstract][Full Text] [Related]
33. Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization.
Naito Y; Tanabe Y; Lee AK; Hamel E; Takahashi H
Sci Rep; 2017 Feb; 7():42548. PubMed ID: 28211900
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-β Oligomer-Induced Electrophysiological Mechanisms and Electrical Impedance Changes in Neurons.
Sun S; Ma Q; Sheng Q; Huang S; Wu C; Liu J; Xu J
Sensors (Basel); 2024 Feb; 24(4):. PubMed ID: 38400369
[TBL] [Abstract][Full Text] [Related]
35. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
[TBL] [Abstract][Full Text] [Related]
36. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
37. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.
Ferreira ST; Klein WL
Neurobiol Learn Mem; 2011 Nov; 96(4):529-43. PubMed ID: 21914486
[TBL] [Abstract][Full Text] [Related]
38. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
Brody AH; Strittmatter SM
Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
40. AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models.
Selles MC; Fortuna JTS; Cercato MC; Santos LE; Domett L; Bitencourt ALB; Carraro MF; Souza AS; Janickova H; Azevedo CV; Campos HC; de Souza JM; Alves-Leon S; Prado VF; Prado MAM; Epstein AL; Salvetti A; Longo BM; Arancio O; Klein WL; Sebollela A; De Felice FG; Jerusalinsky DA; Ferreira ST
Mol Ther; 2023 Feb; 31(2):409-419. PubMed ID: 36369741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
